Analysts Stocks

      BTIG raises MDAI target to $4, stays Buy

      BTIG analyst Ryan Zimmerman lifted their price target on MDAI to $4 on May 27, with the rating unchanged at Buy.

      Ryan has made 11 price-target calls on MDAI that AnaChart has tracked. 1 of 11 were touched by the stock’s price at some point after the call.

      The rating count on MDAI runs 3 Buy right now. Northland Capital Markets‘s Carl Byrnes holds the high end of the range at $6; HC Wainwright‘s Swayampakula Ramakanth anchors the low end at $3.5. The stock’s most recent close was $1.72.

      MDAI price target chart: BTIG raises to $4
      Ryan Zimmerman’s MDAI target history against the street high, street low and the stock price. Each dot marks a dated call.

      The $4 target is 133% above the stock’s $1.72 close.

      FAQ

      What is BTIG’s price target on MDAI?

      BTIG’s Ryan Zimmerman has a $4 target on MDAI, rated Buy, set May 27, 2026.

      How often have Ryan Zimmerman’s MDAI price targets been reached?

      AnaChart has tracked 11 price-target calls from Ryan Zimmerman on MDAI; the stock reached the target in 1 of them (9%).

      What is the analyst view on MDAI?

      Coverage is split 3 Buy / 0 Hold / 0 Sell, with targets from $3.5 (HC Wainwright) to $6 (Northland Capital Markets).